| P2093 | author name string | T M Ludden | |
| | D T Casto | |
| | M S Driscoll | |
| | L C Littlefield | |
| P2860 | cites work | Estimation of population characteristics of pharmacokinetic parameters from routine clinical data | Q28246268 |
| | Genetically determined variability in acetylation and oxidation. Therapeutic implications | Q34682168 |
| | Theophylline pharmacokinetics in the young infant | Q34699880 |
| | Theophylline half-life in infants and young children | Q34710073 |
| | Pharmacokinetics of theophylline in infancy | Q34715417 |
| | Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data | Q36655961 |
| | Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol | Q39288636 |
| | Pharmacokinetic Drug Interactions with Theophylline | Q40094923 |
| | Theophylline A “State of the Art” Review | Q40150067 |
| | A Clinical and Pharmacokinetic Basis for the Selection and Use of Slow Release Theophylline Products | Q40174727 |
| | Sex-Related Differences in Drug Disposition in Man | Q40179654 |
| | Effect of age and sex on theophylline clearance in young subjects | Q41462580 |
| | Intrapatient variability in theophylline kinetics | Q41510935 |
| | Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man | Q41905249 |
| | Relationship of theophylline clearance to oral dosage in children with chronic asthma | Q42050284 |
| | Theophylline metabolism: Variation and genetics | Q42247697 |
| | Pharmacokinetic analysis of the effect of the ophylline on pulmonary function in asthmatic children | Q42597378 |
| | Orciprenaline does not alter theophylline elimination [letter] | Q43241283 |
| | Variation in theophylline clearance rate with time in chronic childhood asthma | Q44131584 |
| | Enhanced biotransformation of theophylline in marihuana and tobacco smokers | Q44659080 |
| | Erratic absorption of a slow-release theophylline sprinkle product. | Q51641117 |
| | Development of hepatic microsomal drug-oxidizing enzymes in immature male and female rats. | Q53728052 |
| | Oral aminophylline therapy. Increased dosage requirements in children | Q67021077 |
| | Pharmacokinetics of theophylline in hepatic disease | Q67326207 |
| | The relation of product formulation to absorption of oral theophylline | Q67381681 |
| | Pharmacokinetic analysis of the disposition of intravenous theophylline in young children | Q67452785 |
| | Dose-dependent kinetics of theophylline disposition in asthmatic children | Q67686638 |
| | Pharmacokinetics of theophylline in children with asthma | Q67827874 |
| | Total theophylline clearance in childhood: the influence of age-dependent changes in metabolism and elimination | Q69021158 |
| | Modelling of individual pharmacokinetics for computer-aided drug dosage | Q69384731 |
| | Rational Intravenous Doses of Theophylline | Q69559621 |
| | Reduction of serum theophylline levels by terbutaline in children with asthma | Q70071066 |
| | Nonlinear theophylline elimination | Q70283773 |
| | Effect of intravenous isoproterenol on theophylline kinetics | Q70313217 |
| | Particle-enhanced turbidimetric inhibition immunoassay for theophylline evaluated with the Du Pont aca | Q70387843 |
| | Sustained-release theophylline for treatment of asthma in preschool children | Q70443255 |
| | Pharmacokinetics of Terbutaline and Theophylline in Guinea Pigs when Administered Simultaneously | Q70748562 |
| | Influence of gender on theophylline dosage requirements in children with chronic asthma | Q70905686 |
| | A comparison of the pharmacokinetics of theophylline in asthmatic children in the acute episode and in remission | Q70940722 |
| | Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria | Q71334382 |
| | Dose-dependent kinetics for theophylline: observations among ambulatory asthmatic children | Q71368145 |
| | Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism | Q71388580 |
| | CLINICAL EVALUATION OF ELIXOPHYLLIN WITH CORRELATION OF PULMONARY FUNCTION STUDIES AND THEOPHYLLINE SERUM LEVELS IN ACUTE AND CHRONIC ASTHMATIC PATIENTS | Q76706598 |
| | Theophylline absorption in young asthmatic children receiving sustained-release formulations | Q93635176 |
| | Clinical and bronchodilating efficacy of controlled-release theophylline as a function of its serum concentrations in preschool children | Q93635178 |
| P433 | issue | 2 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 141-168 | |
| P577 | publication date | 1989-04-01 | |
| P1433 | published in | Journal of Pharmacokinetics and Pharmacodynamics | Q15766045 |
| P1476 | title | Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models | |
| P478 | volume | 17 | |